−189.807MUSD
About Mural Oncology plc
Sector
CEO
Caroline J. Loew
Headquarters
Dublin
Employees (FY)
110
Founded
2017
ISIN
IE000LK2BOB4
Mural Oncology Plc operates as a clinical stage company. It focus on discovering and developing immuno therapies that may meaningfully improve the lives of patients with cancer. Its portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. The company was founded in May 2017 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
